What are the recommended procaterol dosing regimens for adults and children with chronic bronchitis?

Procaterol Dosing for Chronic Bronchitis

Procaterol is not specifically recommended for chronic bronchitis based on current evidence-based guidelines. The most recent CHEST guidelines 1 state there is insufficient evidence to recommend routine use of any bronchodilators specifically for relieving cough in stable chronic bronchitis, and procaterol is not mentioned in any major chronic bronchitis treatment guidelines.

Why Procaterol Is Not the Preferred Choice

The 2020 CHEST expert panel 1 and 2006 ACCP guidelines 2 provide clear recommendations for bronchodilator therapy in chronic bronchitis, but procaterol is notably absent from these recommendations. Instead, guidelines specifically recommend:

• Short-acting β-agonists (generic class recommendation) for bronchospasm and dyspnea 2
• Ipratropium bromide for improving cough (Grade A recommendation) 2
• Long-acting β-agonists combined with inhaled corticosteroids for controlling chronic cough (Grade A recommendation) 2

Evidence Specific to Procaterol

The available research on procaterol shows:

• No efficacy for chronic bronchitis: A 2021 randomized controlled trial 3 demonstrated procaterol was not effective for post-infectious cough in adults, showing no improvement in cough-specific quality of life compared to placebo
• Limited COPD benefit: A 2018 study 4 showed only "modest" improvements when used as assist therapy in stable COPD patients already on long-acting bronchodilators
• Primarily studied in asthma: Most procaterol research focuses on asthma 5, 6, 7, 8, 9, not chronic bronchitis

Recommended Approach for Chronic Bronchitis

For stable chronic bronchitis with cough:

1. First-line: Short-acting β-agonists (albuterol/salbutamol) as needed for bronchospasm 2
2. Second-line: Add ipratropium bromide for persistent cough 2
3. For severe disease (FEV1 <50%): Long-acting β-agonist + inhaled corticosteroid combination 2

For acute exacerbations:

• Short-acting β-agonists or anticholinergic bronchodilators 2
• Add the other class if inadequate response 2
• Antibiotics for bacterial exacerbations 2, 10
• Systemic corticosteroids for 10-15 days 2

Critical Caveat

Smoking cessation remains the most effective intervention, with 90% of patients experiencing cough resolution after quitting 2. This should always be the primary recommendation before considering any pharmacologic therapy.

Dosing Information (If Procaterol Were to Be Used)

While not recommended for chronic bronchitis, if procaterol were prescribed for other indications, research suggests:

• Adults (oral): 50-100 mcg twice daily 11
• Adults (inhaled): 10-20 mcg (1-2 inhalations of 0.01 mg/inhalation) three times daily 7
• Children (oral): 0.5 mcg/kg as starting dose, up to 1.5 mcg/kg for sustained effect 6
• Children (inhaled): 10 mcg with duration of action up to 6-10 hours 8

However, these doses are derived from asthma studies and should not be extrapolated to chronic bronchitis treatment given the lack of supporting evidence and guideline recommendations.